NCT02026843Recruiting
Analysis of Biomarkers From Patients With Chorioretinal Diseases
Source: ClinicalTrials.gov · Last updated 6 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study was conducted to investigate the levels of ocular biomarkers from the patients with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 29 Dec 2013
- Start date
- Apr 2012
- Primary completion date
- Feb 2028
- Lead sponsor
- Kyungpook National University Hospital
- Diseases
- Macular degeneration, Diabetic eye disease
- NCT number
- NCT02026843
What you commit to
- Study type: Observational
- Planned participants: 100
- From Apr 2012 to the primary completion date, Feb 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- patients that received any anti-vascular endothelial growth factor agent for proliferative disease before taking sample of aqueous humor
Other illness
- patients with intraocular inflammations or infections that requiring any pharmaceutical agent
Age
- under the age of 20 years
Other
- patients that did not signed the informed consent of the trial
- patients with recent ocular trauma
Who the study is looking for
- age over 20 years
- patients requiring ophthalmologic treatments for different degrees of decreasing of visual acuity.
- patients with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration.
- control patients asking cataract surgery or vitrectomy for posterior segment nonproliferative disorders.
Age in the registry: 20 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dong Ho Park Coordinator of this site? Confirm its status | Daegu | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.